Author:
Peter S.,Lacher A.,Marschal M.,Hölzl F.,Buhl M.,Autenrieth I.,Kaase M.,Willmann M.
Publisher
Springer Science and Business Media LLC
Subject
Infectious Diseases,Microbiology (medical),General Medicine
Reference43 articles.
1. Poirel L, Nordmann P (2002) Acquired carbapenem-hydrolyzing beta-lactamases and their genetic support. Curr Pharm Biotechnol 3:117–127
2. Zhao WH, Hu ZQ (2010) Beta-lactamases identified in clinical isolates of Pseudomonas aeruginosa. Crit Rev Microbiol 36:245–258
3. Rosenthal VD, Maki DG, Jamulitrat S, Medeiros EA, Todi SK, Gomez DY, Leblebicioglu H, Abu Khader I, Miranda Novales MG, Berba R, Ramirez Wong FM, Barkat A, Pino OR, Duenas L, Mitrev Z, Bijie H, Gurskis V, Kanj SS, Mapp T, Hidalgo RF, Ben Jaballah N, Raka L, Gikas A, Ahmed A, Thu le TA, Guzman Siritt ME (2010) International Nosocomial Infection Control Consortium (INICC) report, data summary for 2003–2008, issued June 2009. Am J Infect Control 38(95–104):e102
4. Willmann M, Marschal M, Holzl F, Schroppel K, Autenrieth IB, Peter S (2013) Time series analysis as a tool to predict the impact of antimicrobial restriction in antibiotic stewardship programs using the example of multidrug-resistant Pseudomonas aeruginosa. Antimicrob Agents Chemother 57:1797–1803
5. Thomson KS (2013) Detection of gram-negative beta-lactamase producing pathogens in the clinical lab. Curr Pharm Des 19:250–256
Cited by
15 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献